Spacer length and serum protein adsorption affect active targeting of trastuzumab-modified nanoparticles
{{output}}
Receptor-mediated active targeting of nanocarriers is a widely investigated approach to specifically address cancerous cells and tissues in the human body. The idea is to use these formulations as drug carriers with enhanced specificity and therefore reduced s... ...